Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at San Francisco, California
Dates
study started
completion around
Principal Investigator
by Peter Chin-Hong, MD
Headshot of Peter Chin-Hong
Peter Chin-Hong

Description

Summary

Demonstrate that the Karius Infectious Disease Diagnostic Sequencing Assay performed on plasma can accurately detect the microbiologic etiology in febrile allogeneic stem-cell transplant patients when compared with standard clinical diagnostics

Keywords

Bone Marrow Transplant Infection, Infections, Communicable Diseases

Eligibility

You can join if…

Open to people ages 18 years and up

  • 18 years of age or older
  • Patients who plan on undergoing an allogeneic stem cell transplant and are admitted to UCSF Medical Center.

You CAN'T join if...

- Inability to provide informed consent and comply with study-related procedures

Location

  • UCSF
    San Francisco California 94143 United States

Lead Scientist at UCSF

  • Peter Chin-Hong, MD
    Peter Chin-Hong is Associate Dean for Regional Campuses. He is a medical educator who specializes in treating infectious diseases, particularly infections that develop in patients who have suppressed immune systems, such as solid organ and hematopoietic stem cell transplant recipients. He was the founding director of the immunocompromised host infectious diseases program at UCSF.

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Karius, Inc.
ID
NCT02804464
Study Type
Observational
Participants
About 70 people participating
Last Updated